DJIA 18,132.70 -81.72 -0.45%
NASDAQ 4,963.53 -24.36 -0.49%
S&P 500 2,104.50 -6.24 -0.30%
market minute promo

MannKind Corp (NASDAQ: MNKD)



company name or ticker

Analysts Weigh in on MannKind Following Q4 Results

Why Second Sight Medical Products Inc. Vaulted Higher Today

Second Sight Medical Products shares continue to surge higher.

MannKind's Financial Statements Can Be Scary To Most Investors

Are Sellers Wrong to Be Short MannKind Corp.?

MannKind Corporation's short interest has soared to more than 80 million shares.

An Objective, We Think, Up-To-Date Look At MannKind

Jefferies Expects Exciting 2015 For MannKind

More Insight Into MannKind's Near-Term Profitability

MannKind Reports Narrower Y/Y Loss in Q4, Afrezza in Focus - Analyst Blog

JPM Securities Picks Through Biotech News For Winners

MannKind Corporation in Transition

A drug on the market for two weeks makes for a boring earnings call.
See More Articles...